PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces

The Centre is planning to create an assessment board to identify the latest and best medical technology for government hospitals on the basis of an independent cost-benefit analysis.In the absence of such guidelines, these decisions are often industry-driven, putting the hapless patient at the recei

In the global scheme of medicines provision, low- and middle-income countries (LMICs) face difficulties in ensuring medicine access. Aside from the improvements still needed to healthcare infrastructure, financing, and service delivery, these countries also face issues in prioritizing their health s

The Health Intervention and Technology Assessment Program (HITAP) would like to invite you to join and learn more about vaccines in a Policy Symposium and Workshop on Vaccinology for Clinical and Public Health Practice in Faridabad (near Delhi), India, on 18-21 November 2019. Join this event to

Patients who are using warfarin, an oral anticoagulant with narrow therapeutic index, needs to be followed up regularly. The index that has been used to monitor the result of using the medicine is International Normalized Ratio (INR). The gold standard of the method to measure INR is to measure using a specific device in the laboratory. However, th

This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymaker

Bhutan\'s Ministry of Health, especially the Essential Medicine and Technology Division (EMTD), is one of HITAP\'s long-term partners. From 2018 to 2019, HITAP with PATH supported Bhutan to conduct an economic evaluation for the implementation of a national program for rotavirus vaccination. HITAP also provided and continues to find opportunities f

In response to expressed interest from the Philippines and other countries in the region on Traditional and Complementary Medicines (T&CM), HITAP and NUS drafted a manuscript titled “Traditional and Complementary Medicines: A review of current technical guidance documents” to summarise the current literature on the topic.For document please

This study aims to assess the use of unblind vs blind expert elicitation for precision medicine